Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

KP-457

Catalog No. T77778Cas No. 1365803-52-6
Alias KP457, KP 457

KP-457 is a specific inhibitor of a disintegrin-metalloproteinase 17 (ADAM17) and a TNFα converting enzyme TACE inhibitor that blocks the production of soluble TNF (sTNF).

KP-457

KP-457

Purity: 98.33%
Catalog No. T77778Alias KP457, KP 457Cas No. 1365803-52-6
KP-457 is a specific inhibitor of a disintegrin-metalloproteinase 17 (ADAM17) and a TNFα converting enzyme TACE inhibitor that blocks the production of soluble TNF (sTNF).
Pack SizePriceAvailabilityQuantity
1 mg$93In Stock
5 mg$228In Stock
10 mg$372In Stock
25 mg$689In Stock
50 mg$1,090In Stock
100 mg$1,480In Stock
1 mL x 10 mM (in DMSO)$243In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "KP-457"

Select Batch
Purity:98.33%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
KP-457 is a specific inhibitor of a disintegrin-metalloproteinase 17 (ADAM17) and a TNFα converting enzyme TACE inhibitor that blocks the production of soluble TNF (sTNF).
Targets&IC50
MMP2:0.717 μM, ADAM10:0.748 μM, MMP9:5.41 μM, MMP17:7.1 μM, MMP8:2.2 μM, MMP13:0.93 μM, ADAM17:0.111 μM, MMP14:2.14 μM, MMP3:9.760 μM
In vitro
b>METHODS: The ability of KP-457 (15 μM) to inhibit GPIbα shedding during in vitro generation of iPSC platelets was studied when administered during the MK differentiation and thrombopoietic stages of HPC cultured at 37°C.
RESULTS: KP-457 had no significant effect on MK numbers; retention of GPIbα by KP-457 was consistently observed in platelets derived from human embryonic stem cells and imMKCLs. [1]
KP-457 is a selective metalloproteinase 17 (ADAM17) inhibitor, with selectivity for ADAM17 over other MMPs and ADAM10, with IC50 values ​​of 0.011 μM (ADAM17), 0.748 μM (ADAM10), 0.717 μM (MMP2), 9.760 μM (MMP3), 2.2 μM (MMP8), 5.41 μM (MMP9), 0.93 μM (MMP13), 2.140 μM (MMP14), and 7.1 μM (MMP17), respectively. [1]
AliasKP457, KP 457
Chemical Properties
Molecular Weight480.56
FormulaC21H24N2O7S2
Cas No.1365803-52-6
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 100 mg/mL (208.09 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.0809 mL10.4045 mL20.8091 mL104.0453 mL
5 mM0.4162 mL2.0809 mL4.1618 mL20.8091 mL
10 mM0.2081 mL1.0405 mL2.0809 mL10.4045 mL
20 mM0.1040 mL0.5202 mL1.0405 mL5.2023 mL
50 mM0.0416 mL0.2081 mL0.4162 mL2.0809 mL
100 mM0.0208 mL0.1040 mL0.2081 mL1.0405 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy KP-457 | purchase KP-457 | KP-457 cost | order KP-457 | KP-457 chemical structure | KP-457 in vitro | KP-457 formula | KP-457 molecular weight